Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zanni

Showing results (861-870 of 943) with videos related to

Pageof 95
Sort By:
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
Critical Care (London, England)|December 6, 2014
Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adultsCarol L Hodgson, Kathy Stiller, Dale M Needham, et al.
Blood|June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphomaSimone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
AIDS (London, England)|July 25, 2022
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease riskKathleen V Fitch, Sara A McCallum, Kristine M Erlandson, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Circulation. Heart Failure|December 29, 2025
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Gerald S Bloomfield, Maya Watanabe, Sara McCallum, et al.
The Lancet. HIV|January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVESteven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2024
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical FunctionKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
European Journal of Human Genetics : EJHG|October 11, 2024
Pathogenic cryptic variants detectable through exome data reanalysis significantly increase the diagnostic yield in Joubert syndromeFulvio D'Abrusco, Valentina Serpieri, Cecilia Maria Taccagni, et al.
Pageof 95

Showing results (861-870 of 943) with videos related to

Sort By:
Pageof 95
JCI Insight|February 22, 2023
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIVSamuel R Schnittman, Wonyeong Jung, Kathleen V Fitch, et al.
Journal of the American Heart Association|December 11, 2025
Baseline ECG and Cardiovascular Outcomes in People With HIV: Insights From REPRIEVEAya Awwad, Christopher de Filippi, Heather Ribaudo, et al.
Critical Care (London, England)|December 6, 2014
Expert consensus and recommendations on safety criteria for active mobilization of mechanically ventilated critically ill adultsCarol L Hodgson, Kathy Stiller, Dale M Needham, et al.
Blood|June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphomaSimone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
AIDS (London, England)|July 25, 2022
Diet in a global cohort of adults with HIV at low-to-moderate traditional cardiovascular disease riskKathleen V Fitch, Sara A McCallum, Kristine M Erlandson, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Circulation. Heart Failure|December 29, 2025
Heart Failure Risk and Events in People With HIV: The Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Gerald S Bloomfield, Maya Watanabe, Sara McCallum, et al.
The Lancet. HIV|January 20, 2025
Performance of the pooled cohort equations and D:A:D risk scores among individuals with HIV in a global cardiovascular disease prevention trial: a cohort study leveraging data from REPRIEVESteven K Grinspoon, Markella V Zanni, Virginia A Triant, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2024
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical FunctionKristine M Erlandson, Triin Umbleja, Heather J Ribaudo, et al.
European Journal of Human Genetics : EJHG|October 11, 2024
Pathogenic cryptic variants detectable through exome data reanalysis significantly increase the diagnostic yield in Joubert syndromeFulvio D'Abrusco, Valentina Serpieri, Cecilia Maria Taccagni, et al.
Pageof 95